Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies
Geron Corp (NASDAQ: GERN) Delayed: 1.15 +0.01 (0.88%)
Previous Close $1.14    52 Week High $5.30 
Open $1.14    52 Week Low $1.81 
Day High $1.17    P/E N/A 
Day Low $1.12    EPS $-0.35 
Volume 8,110,793